Top
This site is intended for healthcare professionals only
Sign InRegister
CDSCO Allows Import Of Drugs With Residual Shelf Life Less Than 60 Percent Till October 31, 2021CDSCO Allows Import Of Drugs With Residual Shelf Life Less Than 60 Percent Till October 31, 2021
Jubilant Pharma develops novel oral formulation of Remdesivir, seeks DCGI nod for additional studiesJubilant Pharma develops novel oral formulation of Remdesivir, seeks DCGI nod for additional studies
Johnson and Johnson seeks CDSCO nod for COVID vaccine Phase 3 trialJohnson and Johnson seeks CDSCO nod for COVID vaccine Phase 3 trial
Bruck Pharma top executive arrested for alleged black marketing of RemdesivirBruck Pharma top executive arrested for alleged black marketing of Remdesivir
CDSCO extends Licence validity for 8 medical devices by additional 6 monthsCDSCO extends Licence validity for 8 medical devices by additional 6 months
Dr Reddys out of key antiviral drug Remdesivir stockDr Reddys out of key antiviral drug Remdesivir stock
Remdesivir production being doubled to 74.1 lakh per month by May: Dr Harsh VardhanRemdesivir production being doubled to 74.1 lakh per month by May: Dr Harsh Vardhan
Alembic, Sun Pharma recall Ganirelix Acetate, Metformin HCL respectively in USAlembic, Sun Pharma recall Ganirelix Acetate, Metformin HCL respectively in US
Brazil approves Bausch Health, Nicox intraocular pressure treatment VYZULTABrazil approves Bausch Health, Nicox intraocular pressure treatment VYZULTA
Bombay HC Directs Setting up Centralized Portal for Availability of Remdesivir, TocilizumabBombay HC Directs Setting up Centralized Portal for Availability of Remdesivir, Tocilizumab
Prices of Remdesivir slashed, now as cheap as Rs 899, says NPPAPrices of Remdesivir slashed, now as cheap as Rs 899, says NPPA
FY 21: Indian pharma exports grow at 18 percent to 24.44 billionFY 21: Indian pharma exports grow at 18 percent to 24.44 billion
X
X